Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Revenue: 2014-2020

Historic Revenue for KalVista Pharmaceuticals (KALV) over the last 6 years, with Apr 2020 value amounting to $3.8 million.

  • KalVista Pharmaceuticals' Revenue rose 30.69% to $3.8 million in Q2 2020 from the same period last year, while for Apr 2020 it was $12.7 million, marking a year-over-year decrease of 21.31%. This contributed to the annual value of -$5.8 million for FY2025, which is 111.57% down from last year.
  • According to the latest figures from Q2 2020, KalVista Pharmaceuticals' Revenue is $3.8 million, which was up 142.49% from $1.6 million recorded in Q1 2020.
  • Over the past 5 years, KalVista Pharmaceuticals' Revenue peaked at $5.6 million during Q4 2018, and registered a low of $7,000 during Q1 2016.
  • Over the past 3 years, KalVista Pharmaceuticals' median Revenue value was $3.8 million (recorded in 2018), while the average stood at $3.6 million.
  • Per our database at Business Quant, KalVista Pharmaceuticals' Revenue plummeted by 90.15% in 2017 and then skyrocketed by 4,145.61% in 2018.
  • Over the past 5 years, KalVista Pharmaceuticals' Revenue (Quarterly) stood at $197,000 in 2016, then skyrocketed by 472.08% to $1.1 million in 2017, then spiked by 396.18% to $5.6 million in 2018, then fell by 29.90% to $3.9 million in 2019, then surged by 30.69% to $3.8 million in 2020.
  • Its Revenue stands at $3.8 million for Q2 2020, versus $1.6 million for Q1 2020 and $3.9 million for Q4 2019.